» Articles » PMID: 7021010

The Basal Plasma Glucose: a Simple Relevant Index of Maturity-onset Diabetes

Overview
Specialty Endocrinology
Date 1981 Mar 1
PMID 7021010
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The 'basal' plasma glucose, defined as the stable overnight concentration, has been assessed as an index of diabetes control by comparison with plasma glucose measurements during 24-h profiles in diet-treated maturity-onset diabetic patients and normal subjects. The basal plasma glucose correlated with the total (r=0.98) and incremental (r=0.86) glucose areas, as well as the 24-h M value (r=0.90). In mild diabetes the basal value was more abnormal than the incremental glucose area after meals, since 3 h after meals 'reactive hypoglycaemia' lowered the plasma glucose to less than the basal value. Thus diabetics with a raised basal glucose up to 8 mmol/l can have a normal 3-h post-prandial value. A raised basal plasma glucose provides similar diagnostic information to conventional oral glucose tolerance tests and provides an apposite measure of diabetes control. Diabetics who come up to a clinic, or who exercise whilst fasting, have fasting plasma glucose and insulin concentrations slightly higher than their overnight 'basal' levels, whereas there is little change in normal subjects. This higher 'stressed fasting' plasma glucose needs to be taken into account when assessing fasting plasma glucose values.

Citing Articles

A moderate physiological dose of benzyl butyl phthalate exacerbates the high fat diet-induced diabesity in male mice.

Zhang J, Powell C, Kay M, Park M, Meruvu S, Sonkar R Toxicol Res (Camb). 2020; 9(4):353-370.

PMID: 32905190 PMC: 7467250. DOI: 10.1093/toxres/tfaa037.


The Need to Calculate Target Glucose Levels When Measuring Changes in Insulin Sensitivity During Interventions for Individuals With Type 2 Diabetes.

Othman N, Docherty P, Krebs J, Bell D, Chase J J Diabetes Sci Technol. 2018; 12(3):665-672.

PMID: 29295634 PMC: 6154237. DOI: 10.1177/1932296817750402.


The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes.

Othman N, Docherty P, Krebs J, Bell D, Chase J Biomed Eng Online. 2015; 14:18.

PMID: 25881031 PMC: 4350631. DOI: 10.1186/s12938-015-0015-7.


High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus.

Ilyas R, Wallis R, Soilleux E, Townsend P, Zehnder D, Tan B Immunobiology. 2010; 216(1-2):126-31.

PMID: 20674073 PMC: 3088832. DOI: 10.1016/j.imbio.2010.06.002.


Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c.

Han B, Hao C, Tchekneva E, Wang Y, Lee C, Ebrahim B Am J Physiol Endocrinol Metab. 2008; 295(4):E981-6.

PMID: 18664598 PMC: 2575908. DOI: 10.1152/ajpendo.90283.2008.